Impaired contractile response of mesenteric arteries in Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 10, 2000, Pages 1279-1285

  Lebuffe, G ^a,b   Haddad, E ^a,b   Desreumaux, P ^a,b   Gambiez, L ^a,b   Colombel, J F ^a,b   Vallet, B ^a,b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CALCIMYCIN; CALCIUM IONOPHORE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; PRIORITY JOURNAL;

EID: 0033794558     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00838.x     Document Type: Article

References (31)

1. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction
2. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin
3. Ulceration of the ileum in Crohn's disease: Correlation with vascular anatomy
4. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease
5. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
6. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
7. Infliximab for the treatment of fistulas in patients with Crohn's disease
8. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease
9. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin
10. Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation
11. Nitric oxide: Physiology, pathophysiology and pharmacology
12. Incidence of inflammatory bowel disease in northern France (1988-90)
13. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock
14. Significance of systemic endotoxaemia in inflammatory bowel disease
15. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
16. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
17. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
18. Changes in splanchnic hemodynamics in inflammatory bowel disease. Non invasive assessment by Doppler ultrasound flowmetry
19. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease
20. Regional intestinal blood flow in ulcerative colitis and Crohn's disease
21. Role of nitric oxide in gastrointestinal and hepatic function and disease
22. Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats
23. Nitric oxide in the gut
24. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle
25. Nitric oxide: A novel signal transduction mechanism for transcellular communication
26. Crohn's disease: Pathogenesis and persistent measles virus infection
27. Granulomatous vasculitis in Crohn's disease
28. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries
29. Endotoxin in vivo impairs endothelium-dependent canine arteries in vitro
30. Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta
31. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia